A dual-plasmid CRISPR/Cas9-based method for rapid and efficient genetic disruption in Mycobacterium abscessus
Journal of Bacteriology · 2024
DOI: 10.1128/jb.00335-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Bacteriology, 2024. Verfasst von Donavan Marcus Neo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Mycobacterium abscessus. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Broad Institute Tuberculosis Donor Group, Pershing Square Foundation (PSF).
Abstract (Originalsprache)
Mycobacterium abscessus is increasingly recognized for causing infections that are notoriously difficult to treat, owing to its large arsenal of intrinsic antibiotic resistance mechanisms. Tools for the genetic manipulation of the pathogen are critical for enabling a better understanding of M. abscessus biology, pathogenesis, and antibiotic resistance mechanisms. However, existing methods are largely recombination-based, which are relatively inefficient. Meanwhile, CRISPR/Cas9 has revolutionized the field of genome editing including its recent adaptation for use in mycobacteria. In this study, we report a streamlined and efficient method for rapid genetic disruptions in M. abscessus . Harnessing the CRISPR1 loci from Streptococcus thermophilus , we have developed a dual-plasmid workflow that introduces Cas9 and sgRNA cassettes in separate steps but requires no other additional factors to engineer mutations in single genes or multiple genes simultaneously or sequentially using multiple targeting sgRNAs. Importantly, the efficiency of mutant generation is several orders of magnitude higher than reported for homologous recombination-based methods. This work, thus, reports the first application of CRISPR/Cas9 for gene editing in M. abscessus and is an important tool in the arsenal for the genetic manipulation of this human pathogen. IMPORTANCE Mycobacterium abscessus is an opportunistic pathogen of increasing clinical importance due to its poor clinical outcomes and limited treatment options. Drug discovery and development in this highly antibiotic-resistant species will require further understanding of M. abscessus biology, pathogenesis, and antibiotic resistance mechanisms. However, existing methods for facile genetic engineering are relatively inefficient. This study reports on the first application of CRISPR/Cas9 for gene editing in M. abscessus using a dual-plasmid workflow. We establish that our method is easily programmable, efficient, and versatile for genetic disruptions in M. abscessus . This is a critical advancement to facilitating targeted gene function studies in this emerging pathogen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
- Department of Molecular Biology and Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Donavan Marcus Neo, Deborah T Hung
Förderung
- Broad Institute Tuberculosis Donor Group
- Pershing Square Foundation (PSF)
Zitieren
APA
Neo, D. M., Clatworthy, A. E., & Hung, D. T. (2024). A dual-plasmid CRISPR/Cas9-based method for rapid and efficient genetic disruption in Mycobacterium abscessus. Journal of Bacteriology. https://doi.org/10.1128/jb.00335-23
Vancouver
Neo DM, Clatworthy AE, Hung DT. A dual-plasmid CRISPR/Cas9-based method for rapid and efficient genetic disruption in Mycobacterium abscessus. Journal of Bacteriology. 2024. doi:10.1128/jb.00335-23
BibTeX
@article{Neo2024,
author = {Neo, Donavan Marcus and Clatworthy, Anne E and Hung, Deborah T},
title = {A dual-plasmid CRISPR/Cas9-based method for rapid and efficient genetic disruption in Mycobacterium abscessus},
journal = {Journal of Bacteriology},
year = {2024},
doi = {10.1128/jb.00335-23}
}
EUVIMED